AMERICAN SOCIETY OF
CLINICAL ONCOLOGY
ROMANIAN NATIONAL SOCIETY
OF MEDICAL ONCOLOGY
SECOND ANNOUNCEMENT
ASCO – SNOMR SYMPOSIUM
„NEW TRENDS IN MEDICAL
ONCOLOGY”
THE 10TH
NATIONAL CONFERENCE OF
MEDICAL ONCOLOGY
„ACTUALITIES IN MEDICAL ONCOLOGY”
13-16 OCTOBER 2011
Hotel PIATRA MARE
POIANA BRASOV
ROMANIA
PRELIMINARY SCIENTIFIC PROGRAMME
|
Zi
de conferinta |
Cursuri
teoretice |
|
Titlu
sesiune |
Lucrari
stiintifice |
|
Simpozion
ASCO |
Sesiune
speciala |
|
THURSDAY, 13TH OCTOBER |
||
|
|
|
|
|
15:30
- 16:00 |
THE
OPENING OF 10TH NATIONAL CONFERNCE OF ONCOLOGY |
|
|
|
|
|
|
16:00
- 17:00 |
ORIGINAL
STUDIES - CLINICAL EXPERIENCE IN ROMANIAN ONCOLOGY NETWORK |
POSTER
PRESENTATION - SESSION 1 |
|
|
|
|
|
17:00
- 17:30 |
Aplicarea principiilor de medicina integrativa in terapiile complementare antitumorale |
Dr. Gheorghiev Gheorghi |
|
|
|
|
|
17:30
- 19:00 |
ROLE
OF PET CT IN DIAGNOSTIC OF MALIGNANT TUMORS |
|
|
17:30
- 17:50 |
PET-CT Detection Of Recurrent Ovarian Cancer In Patients With Increasing CA 12-5 |
Dr. Catalin Mazilu, Dr. George Ionescu, Fiz. Pr. Constantin Popescu |
|
|
|
|
|
17:50
- 18:10 |
Metastases with unknown primary tumor – PET/CT role |
Dr. George Ionescu, Dr. Catalin Mazilu, Fiz. Pr. Constantin Popescu |
|
|
|
|
|
18:10
- 18:40 |
Imaging complementary
methods in ocological diagnostic |
Dr. Oana Amza |
|
|
|
|
|
18:40
- 19:00 |
PET/CT and SPECT/CT Multimodality molecular imaging systems – applications in oncology: image fusion, radiotracer specificity, SUV, detection limit, patient radiation dose/exposure |
Fiz. Pr. Constantin Popescu, Dr. C. Chirion, Dr. R. Vladescu, Dr. Catalin Mazilu, Dr. George Ionescu |
|
|
|
|
|
19:00
- 19:30 |
MALIGNANT
MELANOMA - NEW TREATMENT OPPORTUNITIES - I |
|
|
19:00
- 19:30 |
Ipilimumab - new treatment option for malignant melanoma |
Conf Dr Tudor Eliade Ciuleanu |
|
|
|
|
|
20:00 |
SOCIAL
EVENT. WELLCOME COCKTAIL |
|
|
|
|
|
|
FRIDAY, 14TH OCTOBER |
||
|
|
|
|
|
08:30
- 10:45 |
TREATMENT
OF HER2 POSITIVE BREAST CANCER - CLINICAL ROUTINE EXPERIENCE AND CLINICAL
RESEARCH EXPERIENCE |
|
|
08:30
- 08:45 |
HER2 testing in breast carcinomas –local approach. |
Prof. Dr. Carmen Ardeleanu |
|
|
|
|
|
08:45
- 09:00 |
Trastuzumab benefits over HER2 + breast cancer treatment with HR negative . |
Dr. Tanasescu Radu |
|
|
|
|
|
09:00
- 09:15 |
Trastuzumab therapy in the adjuvant status -concomitant vs sequential therapy . |
Dr. Florin Bacanu |
|
|
|
|
|
09:15
- 09:30 |
HERA trial 4 years follow-up overview . |
Dr. Serban Negru |
|
|
|
|
|
09:30
- 09:45 |
Management of Her2+ breast cancer patients with HR positive. |
Dr. Dana Grecea |
|
|
|
|
|
09:45
- 10:00 |
Trastuzumab treatment for men with Her2 positive breast cancer . |
Dr. Rosioru Benonia |
|
|
|
|
|
10:00
- 10:15 |
Particularities of HER2 3+ metastatic breast cancer patients treated with Trastuzumab . |
Dr. Morar Bolba Gabriela |
|
|
|
|
|
10:15
- 10:30 |
Safety profile in breast cancer patients treated with Trastuzumab for their Her2+ disease. |
Dr. Simona Mihutiu |
|
|
|
|
|
10:30
- 10:45 |
Insights on small tumors breast cancer patients after Trastuzumab treatment |
Dr. Dana Stanculeanu |
|
|
|
|
|
10:45
- 11:00 |
COFFEE
BREAK |
|
|
|
|
|
|
11:00
– 11:30 |
MALIGNANT MELANOMA - NEW TREATMENT OPPORTUNITIES - II |
|
|
11:00
– 11.30 |
Perspectives in treatment of malignant melanoma |
Peter Mohr MD PhD, Center of Dermatology Elbeklinikum Buxtehude, Germany |
|
|
|
|
|
11:30
- 12:50 |
BREAST
CANCER HORMONAL TREATMENT AND BISPHOSPHONATES |
|
|
11:30
- 11:50 |
Aromatase Inhibitors in the Adjuvant Setting of Early Breast Cancer: from in vitro activity to clinical efficacy |
Dr. Daniela Grecea |
|
|
|
|
|
11:50
- 12:10 |
Updates in hormonotherapy of breast cancer |
Dr Motan Ganea Doina Elena (to be confirmed) |
|
|
|
|
|
12:10
- 12:30 |
Fulvestrant - new option, confirmed eficcacy in hormonal treatment of breast cancer |
Dr. Dana Stanculeanu |
|
|
|
|
|
12:30
- 12:50 |
Clinical Evidence Supporting Anticancer Activity of Bisphosphonates: Insights From Breast Cancer |
Dr. Mircea Dediu (to be confirmed) |
|
|
|
|
|
12:50
– 14:00 |
LUNCH
BREAK |
|
|
|
|
|
|
14:00
– 14:20 |
SUPPORTIVE
CARE: FEBRILE NEUTROPENIA |
|
|
14:00
– 14:20 |
How febrile neutropenia can be prevented optimally? |
Conf Dr Tudor Eliade Ciuleanu (to be confirmed) |
|
|
|
|
|
14:20
– 15:10 |
SUPPORTIVE
CARE. ANEMIA Argumentes and contra-argumentes in chemotherapy-induced anemia
(CIA) |
|
|
14:20
– 14.35 |
Transfusions vs. Eritropoesis stymulating agents (ESA) |
Pro transfuzii: A. Cucuianu |
|
|
|
Pro ESA: H. Bumbea |
|
|
|
|
|
14.35
– 14:50 |
Based on existing data, can ESA be safety administrated in CIA? |
Pro: R. Curca |
|
|
|
Contra: M. Dediu |
|
|
|
|
|
14.50
– 15.10 |
There is clinically relevant differences between first generation ESA (epoetina alfa, -beta) and second generation ESA (darbepoetina)? |
Pro: L. Ciule |
|
|
|
Contra: M. Stanculeanu |
|
|
|
|
|
15:10
- 16:00 |
ECONOMY
BURDENS IN MODERN ONCOLOGY - COST EFFICACY ANALYSIS OF SPECIFIC TOPICS |
|
|
15:10
- 15:40 |
Cost constrains in
oncology |
Prof. Paul Cornes |
|
|
|
|
|
15:40
- 16:00 |
Cost-efficacy in oncology: target therapy in renal carcinoma |
Dr. Florian Berghea |
|
|
|
|
|
16:00
- 16:15 |
COFEE
BREAK |
|
|
|
|
|
|
16:15
- 19:15 |
ASCO
- SNOMR SYMPOSIUM - NEW TREND IN MEDICAL ONCOLOGY - I |
|
|
16:15
- 16:20 |
Welcome. Introduction to symposium |
Dr. Alexandru Grigorescu |
|
|
|
|
|
16:20
- 16:50 |
Lung cancer updates |
Prof Paris Kosmidis |
|
|
|
|
|
16:50
- 16:05 |
Lung cancer case presentation |
Dr. Alexandru Grigorescu |
|
|
|
|
|
16:05
- 17.15 |
Lung cancer - discussion |
|
|
|
|
|
|
17:15
- 17:45 |
Breast cancer updates |
Prof. Sandra Swain |
|
|
|
|
|
17:45
- 18:00 |
Breast cancer case presentation |
Dr. Alexandru Eniu |
|
|
|
|
|
18:00
- 18:10 |
Breast cancer - discussion |
|
|
|
|
|
|
18:10
- 18:30 |
COFEE
BREAK |
|
|
|
|
|
|
18:30
- 18:55 |
Active immunotherapy for cancer. Part I: Sipuleucel-T for treatment of metastatic prostate cancer |
Mihaela Popa McKiver |
|
|
|
|
|
18:55
- 19:20 |
Active immunotherapy for cancer. Part II: BiovaxID for consolidation of first-line remission in follicular Non-Hodgkin Lymphoma |
Mihaela Popa McKiver |
|
|
|
|
|
20:00 |
SOCIAL
EVENT |
|
|
|
|
|
|
SATURDAY, 15TH OCTOBER |
||
|
|
|
|
|
08:30
– 11:40 |
ASCO
- SNOMR SYMPOSIUM - NEW TREND IN MEDICAL ONCOLOGY - II |
|
|
|
|
|
|
08:30
- 09:00 |
Basic research , transitional research importance for clinical practice |
Iuliana Gruia MD |
|
|
|
|
|
09:00
- 09:30 |
Targeted therapies in oncology |
Paul Doru MD |
|
|
|
|
|
10:00
– 11:40 |
COFEE
BREAK |
|
|
|
|
|
|
10:00
- 10:30 |
Colorectal cancer update |
Conf Dr Adriana Badulescu, Prof. Dr. Florinel Badulescu |
|
|
|
|
|
10:30
- 10:50 |
Colorectal cancer case presentation |
Paul Doru MD |
|
|
|
|
|
10:50
– 11:20 |
Surgery in pancreatic tumors: advances and limitations! |
Prof. Doris Henne-Bruns* SPECIAL INVITED |
|
|
|
|
|
11:20
– 11:40 |
Medical Oncology and Palliative Care, ESMO designed Centers. Conclusions of the symposium |
Dr. Alexandru Grigorescu |
|
|
|
|
|
11:40
- 12:20 |
SPECIAL TOPIC: Prof. Doris Henne-Bruns and Prof. Michael Untch - Free lecture - Experience in treating cancer
patients, from diagnostic to recent and modern treatments |
Prof. Dr. Doris Henne-Bruns and Prof. Dr. med. Michael Untch |
|
|
|
|
|
12:20
- 13:20 |
LUNCH
BREAK |
|
|
|
|
|
|
13:20
- 13:40 |
Chemoembolization in hepatocellular carcinoma |
Dr. Mugur Grasu, Dr. Aurel Fernye, Dr. Radu Dumitru |
|
|
|
|
|
13:40
– 14:00 |
Translational Cell Culture Studies in Cancer Research: From Bench to Bed |
Associate Professor Burcak Karaca MD PhD, Oncology Department, University of Izmir |
|
|
|
|
|
14:00
- 15:10 |
CHANGING
IN THE BEST STANDARD OF CARE: BREAST CANCER, GASTRO-INTESTINAL STROMAL TUMORS
AND NET TUMORS |
|
|
14:00
- 14:20 |
A new era in GIST management |
Conf. Dr. Adriana Badulescu, Prof. Dr. Florinel Badulescu |
|
|
|
|
|
14:20
- 14:40 |
Recent advances in medical treatment of NET |
Dr Michael Schenker, Prof. Dr. Florinel Badulescu |
|
|
|
|
|
14:40
- 15:10 |
How to treat my patients with HER2+ metastatic breast cancer? |
Prof. Dr. med. Michael Untch, Chefarzt der Frauenklinik, HELIOS Klinikum Berlin-Buch* SPECIAL INVITED |
|
|
|
|
|
15:10
- 15:30 |
COFEE
BREAK |
|
|
|
|
|
|
15:30
- 16:30 |
SUPPORTIVE
CARE. CANCER PAIN |
|
|
15:30
- 16:00 |
Toghether against cancer pain |
Dr. Oana Donea, Asociatia pentru Servicii Mobile de Ingrjire Paliativa (SMIP) |
|
|
|
|
|
16:00
- 16:30 |
Pain therapy: fears and opportunities |
Prof. Dr. Ostin Mungiu, UMF Gr T Popa Iasi |
|
|
|
|
|
16:30
- 18:30 |
GENITO-URINARY
MALIGNANCIES - RECENT ADVANCES |
|
|
|
|
|
|
16:30
- 17:00 |
Treatment options in metastatic prostate cancer following PSA rising after initial hormonal treatment |
Dr. Gabriel Kacso |
|
|
|
|
|
17:00
- 17:30 |
TROPIC Study, Cabazitaxel+prednison ( CBZP) vs Mitoxantron+prednison (MP) in treatment of metastatic homono-refractory prostate cancer, pretreated with docetaxel |
Dr. Anca Mihailov |
|
|
|
|
|
17:30 - 18:00 |
Everolimus: The Standard of Care for Patients with VEGFr-TKI Refractory mRCC |
Conf Dr Tudor Eliade Ciuleanu (to be confirmed) |
|
|
|
|
|
18:00
-18:30 |
Current Perspectives and Future Directions with Bone-Targeted Therapies in GU Malignancies |
Dr. Gabriel Kacso |
|
|
|
|
|
20:00 |
SOCIAL
EVENT |
|
|
|
|
|
|
SUNDAY 16TH OCTOBER |
||
|
|
|
|
|
08:30
- 10:00 |
ORIGINAL
STUDIES - CLINICAL EXPERIENCE IN ROMANIAN ONCOLOGY NETWORK |
POSTER
PRESENTATION - SESSION 2 |
|
|
|
|
|
10:00
- 10:15 |
CLOSING
OF 10TH NATIONAL CONFERNCE OF ONCOLOGY; CONCLUSIONS, NEXT CONFERENCE - 2012 |
|
|
|
|
|
|
10:15
- 12:00 |
GENERAL
ENSAMBLLY OF NATIONAL SOCIETY OF MEDICAL ONCOLOGY FROM ROMANIA |
|